Bloomberg Talks

Novo Nordisk CEO Talks Weight Loss Drug Supply

May 2, 2024
Guest
Romaine Bostick
Guest
Katie Greifeld
Guest
Lars Fruergaard Jorgensen
Novo Nordisk CEO discusses scaling up production of weight-loss drug Wegovy with Bloomberg journalists. Topics include manufacturing capacity, unit costs, pricing strategies in drug production, long-term use of weight loss drugs, administration routes, and personalized medicine.
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 3min
2
Discussion on Manufacturing Capacity, Unit Costs, and Pricing Strategies in Drug Production
03:20 • 6min
3
Exploring Long-Term Use and Administration Routes of Weight Loss Drugs
08:53 • 4min